Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

2.38
+0.04001.71%
Post-market: 2.450.0698+2.93%19:57 EDT
Volume:80.80K
Turnover:195.66K
Market Cap:5.64M
PE:-0.21
High:2.52
Open:2.35
Low:2.29
Close:2.34
Loading ...
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Correspondence

Form CORRESP - Correspondence
Nov 18, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Oct 20, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 28, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 03, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Correspondence

Form CORRESP - Correspondence
May 09, 2023

Correspondence

Form CORRESP - Correspondence
May 09, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933